乳腺癌幸存者中放射治疗长期不良反应的种族和民族差异
本研究基于德克萨斯州癌症登记处2009至2014年确诊的0-II期乳腺癌接受肿块切除和放疗的患者开展横断面调查研究,2770例被采样,631例回复(23%)。与白人患者相比,美洲印第安人或阿拉斯加原住民、黑人及西班牙裔患者的BREAST-Q放射治疗不良反应评分更差,且年龄<50岁、教育程度低于大学、胸罩罩杯D/E及当前吸烟也与更差评分相关。
要点
- 美洲印第安人或阿拉斯加原住民、黑人及西班牙裔患者报告的长期乳腺和皮肤生活质量结局显著差于白人患者。
- 年龄<50岁较≥65岁、教育程度低于大学、胸罩罩杯D/E及当前吸烟与更差的BREAST-Q放射治疗不良反应评分相关。
- 需要进一步研究以理解这些差异并寻找缓解方法。
核心结论
- 美洲印第安人或阿拉斯加原住民、黑人及西班牙裔患者在放射治疗后报告的长期乳腺和皮肤生活质量结局显著差于白人患者。
- 需要进一步研究以理解这些差异并寻找缓解方法。
研究设计与样本
- 横断面调查研究,对象为德克萨斯州癌症登记处2009至2014年确诊的0-II期乳腺癌并接受肿块切除和放射治疗的患者。
- 共采样2770例患者,631例回复(23%)。
- 使用BREAST-Q放射治疗不良反应总体评分及子指数测量放射治疗对乳腺组织的影响,并采用多变量逻辑回归评估人口学和治疗特征与结局的关联。
主要发现
- 中位年龄57岁(IQR,48-65),中位自诊断至调查回复时间9年(IQR,7-10)。
- 队列包括62例亚裔美国人或太平洋岛民(9.8%)、11例美洲印第安人或阿拉斯加原住民(1.7%)、161例黑人(25.5%)、144例西班牙裔(22.8%)和253例白人(40.1%)患者。
- 与白人患者相比,美洲印第安人或阿拉斯加原住民患者的BREAST-Q放射治疗不良反应平均评分更差(-22.2;95%CI,-39.9至-4.6;P=.01),黑人患者更差(-10.8;95%CI,-16.1至-5.5;P<.001),西班牙裔患者更差(-7.8;95%CI,-13.0至-2.5;P=.004)。
- 与≥65岁相比,年龄<50岁的效应量为-8.6(95%CI,-14.0至-3.2;P=.002);教育程度低于大学的效应量为-5.8(95%CI,-10.0至-1.6;P=.01)。
- 与胸罩罩杯A/B相比,罩杯D/E的效应量为-5.3(95%CI,-9.9至-0.65;P=.03);当前吸烟者的效应量为-11.3(95%CI,-18.3至-4.2;P=.002)。
关键数值与推荐
- BREAST-Q放射治疗不良反应总体评分用于测量放射治疗对乳腺组织的影响。
- 与白人患者相比,美洲印第安人或阿拉斯加原住民患者评分差异为-22.2(95%CI,-39.9至-4.6;P=.01)。
- 与白人患者相比,黑人患者评分差异为-10.8(95%CI,-16.1至-5.5;P<.001)。
- 与白人患者相比,西班牙裔患者评分差异为-7.8(95%CI,-13.0至-2.5;P=.004)。
- 当前吸烟者效应量为-11.3(95%CI,-18.3至-4.2;P=.002)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 回复率为23%(631/2770)。
- 原文结论指出需要进一步研究以理解这些差异并寻找缓解方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Breast and skin changes are underrecognized side effects of radiation therapy for breast cancer, which may have long-term implications for quality of life (QOL). Racial and ethnic disparities in breast cancer outcomes, including long-term QOL differences after breast radiation therapy, are poorly understood. METHODS AND MATERIALS: We conducted a cross-sectional survey study of patients from the Texas Cancer Registry who received diagnoses of stage 0-II breast cancer from 2009 to 2014 and treated with lumpectomy and radiation therapy; 2770 patients were sampled and 631 responded (23%). The BREAST-Q Adverse Effects of Radiation overall score and subindices measured the effect of radiation therapy on breast tissue. Multivariable logistic regression evaluated associations of demographic and treatment characteristics with outcomes. RESULTS: The median age was 57 years (IQR, 48-65), median time from diagnosis to survey response 9 years (IQR, 7-10), and the cohort included 62 Asian American or Pacific Islander (9.8%), 11 American Indian or Alaskan Native (AIAN) (1.7%), 161 Black (25.5%), 144 Hispanic (22.8%), and 253 White (40.1%) patients. Mean BREAST-Q Adverse Effects of Radiation score was worse for AIAN patients (-22.2; 95% CI, -39.9 to -4.6; P = .01), Black patients (-10.8; 95% CI, -16.1 to -5.5; P < .001), and Hispanic patients (-7.8; 95% CI, -13.0 to -2.5; P = .004) compared with White patients, age <50 compared with ≥65 (effect size -8.6; 95% CI, -14.0 to -3.2; P = .002), less than a college education (-5.8; 95% CI, -10.0 to -1.6; P = .01), bra cup size of D/E versus A/B (-5.3; 95% CI, -9.9 to -0.65; P = .03), and current smokers (-11.3; 95% CI, -18.3 to -4.2; P = .002). AIAN, Black, and Hispanic patients reported worse changes in skin pigmentation, telangiectasias, dryness, soreness, and/or irritation compared with White patients. CONCLUSIONS: AIAN, Black, and Hispanic patients reported substantially worse long-term breast and skin QOL outcomes after radiation therapy. Additional work is needed to understand these differences and how to alleviate them.
引用
- Diao K, Lei X, He W, et al. Racial and Ethnic Differences in Long-Term Adverse Radiation Therapy Effects Among Breast Cancer Survivors. Int J Radiat Oncol Biol Phys. 2023. PMID: 37751792. doi:10.1016/j.ijrobp.2023.09.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。